Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Nefazodone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nefazodone hydrochloride and what is the scope of nefazodone hydrochloride freedom to operate?

Nefazodone hydrochloride
is the generic ingredient in two branded drugs marketed by Sandoz, Dr Reddys Labs Inc, Sun Pharm Inds Ltd, Mylan, Teva, Bristol Myers Squibb, Ivax Sub Teva Pharms, Idt Australia Ltd, Watson Labs, and Roxane, and is included in ten NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for nefazodone hydrochloride. Four suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: nefazodone hydrochloride

Drug Master File Entries: see list3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list55
Clinical Trials: see list991
Patent Applications: see list1,302
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nefazodone hydrochloride at DailyMed

Pharmacology for Ingredient: nefazodone hydrochloride

Tentative approvals for NEFAZODONE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe50MGTABLET;ORAL
► Subscribe► Subscribe250MGTABLET;ORAL
► Subscribe► Subscribe200MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
nefazodone hydrochloride
TABLET;ORAL076409-003Sep 16, 2003DISCNNoNo► Subscribe► Subscribe
nefazodone hydrochloride
TABLET;ORAL076302-005Sep 16, 2003DISCNNoNo► Subscribe► Subscribe
Bristol Myers Squibb
nefazodone hydrochloride
TABLET;ORAL020152-005Dec 22, 1994DISCNYesNo► Subscribe► Subscribe
Idt Australia Ltd
nefazodone hydrochloride
TABLET;ORAL076072-003Sep 16, 2003DISCNNoNo► Subscribe► Subscribe
Watson Labs
nefazodone hydrochloride
TABLET;ORAL076073-005Sep 16, 2003DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus